Back

Cytokinetics CEO Robert I. Blum sells nearly 105,000 company shares

Verifying
  • Robert I. Blum sold nearly 105,000 Cytokinetics shares.
  • Blum’s sales included a major block under a pre-arranged trading plan.
  • Other Cytokinetics executives also recently sold company stock.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.